WuXi Biologics (Cayman) Inc.
2269
Pozycja w akcjach
#987
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Cena akcji
$5.77
Kapitalizacja rynkowa
$23.74B
Zmiana (1 dzień)
-8.38%
Zmiana (1 rok)
25.13%
Kraj
CN
Handel WuXi Biologics (Cayman) Inc. (2269)
Kategoria
Healthcare
Liczba akcji w obrocie dla WuXi Biologics (Cayman) Inc. (2269)
Liczba akcji w obrocie na dzień October 2026: 0
Zgodnie z najnowszymi raportami finansowymi i ceną akcji WuXi Biologics (Cayman) Inc., aktualna liczba akcji w obrocie to 0. Na koniec October 2026 firma posiadała 0 akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla WuXi Biologics (Cayman) Inc. (2269) od 2014 do 2026
Akcje w obrocie na koniec każdego roku
| Rok | Akcje w obrocie | Zmień |
|---|---|---|
| 2025 | 4.18B | 2.29% |
| 2024 | 4.08B | -1.96% |
| 2023 | 4.16B | -0.22% |
| 2022 | 4.17B | -5.18% |
| 2021 | 4.40B | 4.55% |
| 2020 | 4.21B | 5.30% |
| 2019 | 4.00B | 1.42% |
| 2018 | 3.94B | 22.31% |
| 2017 | 3.22B | -5.29% |
| 2016 | 3.40B | 0.00% |
| 2015 | 3.40B | 0.00% |
| 2014 | 3.40B | 0.00% |
Akcje w obrocie dla podobnych firm lub konkurentów
| Firma | Akcje w obrocie | Różnica | Kraj |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| - | - |
CH
|
